4/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: November 19, 2012
Period of Report: October 26, 2012
Accession Number: 0001055947-12-000009

View Document ↗ View on SEC.gov ↗